Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin in cervical dystonia
NCT03232320Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Jul 2017
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cervical dystonia (CD) comparing MEDITOXIN with Placebo (2 arms). Primary endpoint: Change in Toronto Western Spasmodic Torticollis Rating Scale Total Score From Baseline at 4 weeks. Started Jul 2017; status: completed.
02
Drugs
Meditoxin
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT03232320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03232320.